EIDOS THERAPEUTICS, INC.

EIDX NASDAQ
35.36
+0.51
+1.45%
Opening 10:24 07/22 EDT
Open
35.93
Prev Close
34.85
High
35.93
Low
35.32
Volume
17.53K
Avg Vol (3M)
167.19K
52 Week High
41.35
52 Week Low
8.89
% Turnover
0.05%
Market Cap
1.27B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers EIDOS THERAPEUTICS, INC. EIDX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on addressing the unmet need in diseases caused by transthyretin (TTR), amyloidosis (ATTR). It focuses on treating the disease by targeting them at their collective source by stabilizing TTR. The Company’s product candidate, AG10, is an orally-administered small molecule designed to potently stabilize tetrameric TTR, thereby halting at its outset the series of molecular events that give rise to ATTR. AG10 binds and stabilizes TTR in the blood, preventing the formation of amyloid and halting progression of the disease.
MORE >

Recently

Name
Price
%Change